Working... Menu
Trial record 8 of 133 for:    PAP children

Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP) (FAMPAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01511068
Recruitment Status : Completed
First Posted : January 18, 2012
Last Update Posted : June 4, 2014
Virginia Commonwealth University
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2013
  Actual Study Completion Date : February 2014